Niva Bupa Health Insurance Company Ltd

- The document does not mention any current or planned future fundraising through debt or equity by Niva Bupa Health Insurance Company Limited. - The only related information is a mention of a primary capital raise as part of their IPO, which contributed to AUM growth, but no ongoing or future fundraising is indicated. - The investment book is currently almost entirely debt, with negligible recent investment in NIFTY ETF, but this relates to investment strategy, not fundraising. - No explicit plans or announcements about new debt or equity fundraising are discussed in the provided transcript.

The provided pages of the Niva Bupa Health Insurance Company Limited document do not explicitly mention any current or future capex, capital investment, or strategic investment plans. The information mainly covers financial results, growth metrics, claims management, product strategy, hospital network, and discussions around market dynamics and risk management. Key highlights related to investment from the transcript include: - Equity fundraise as part of IPO increased Assets Under Management (AUM) (Page 10). - Investment book primarily consists of debt with negligible equity exposure in NIFTY ETF recently (Page 8). - No specific mention of future capex or strategic investments disclosed during the Q4 FY25 call. Therefore, no detailed disclosures or plans related to capex or strategic investments are mentioned in the available pages.

- The company achieved a 32% growth in Gross Written Premium (GWP) on a like-to-like basis in FY25. - Retail lives covered grew by around 18% in FY25 compared to FY24. - Group health (including employer-employee and loan-attached products) has grown faster than retail business with overall growth around 32%. - The company continues to expand its distribution network, adding 8,000 agents and 30 new distribution partners in the last quarter. - Launch of the new product "Rise" targets the large unserved middle and lower-middle-class segment, expected to drive new customer additions. - The Preferred Provider Network is scaling up, now covering 40 cities and nearly 600 hospitals, enhancing value delivery to customers. - The company aims to maintain disciplined underwriting and claims management supported by technology and analytics, supporting sustainable growth. - Overall, the company expects ongoing growth driven by multi-channel distribution, product innovation, and expanding ecosystem partnerships.

- Niva Bupa reported a strong PAT growth of 91% under IFRS, rising from Rs.106 crores in FY24 to Rs.203 crores in FY25. - Profit under iGAAP also rose significantly by 161%, from Rs.82 crores to Rs.214 crores in FY25. - The company improved its combined ratio on a like-to-like basis to 96.1% in FY25, showing better profitability potential. - Expense of management is on a downward trajectory, improving by 190 bps each year, currently at 37.4%, with a confident glide path to meet regulatory targets (~35.5%). - Continued growth in retail lives (+18%) and GWP (32%) supports earnings momentum. - Emphasis on disciplined underwriting, pricing adjustments, and fraud detection is expected to sustain profitability. - Investment yield stable at 7.4%, with a strong solvency ratio (3.03x), supporting financial robustness. - Management focus on cross-selling, product innovation (e.g., “Rise” product), and expanding distribution further supports medium to long-term earnings growth.

The provided document does not contain any information related to current or expected order book or pending orders for Niva Bupa Health Insurance Company Limited. The content predominantly covers discussions on claims ratio, customer demographics, product design, risk selection, hospital network, expense management, medical inflation, claims settlement ratios, and business growth metrics. No data or references to order books or pending orders are mentioned in the text on page 17 or in the related transcript excerpts. If you have any other questions or need information on a different topic from the document, please feel free to ask.